IMPACT OF GEN-PROBE'S AMPLIFIED MYCOBACTERIUM TUBERCULOSIS DIRECT TEST ON TUBERCULOSIS DIAGNOSIS IN CHILDREN
ESPID Education. Syridou G. 06/07/11; 7725 Disclosure(s): No conflicts of interest
Garyfallia Syridou
Garyfallia Syridou

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Abstract
Discussion Forum (0)
Rate & Comment (0)
The aim of the study was to evaluate the performance of Gen-Probe Amplified Mycobacterium tuberculosis Direct Test (AMTD, Gen-Probe, San Diego, California) for the diagnosis of tuberculosis in children, compared to conventional culture and clinical diagnosis. We retrospectively studied 81 children (48 males; mean age 7 years; range 1-16 years) evaluated for possible active TB. Respiratory samples (n=64/95;67%) submitted to NRLM included gastric aspirates (n=30), induced sputa (n=30), bronchial aspirates and bronho-alveolar lavage (n=4). Non-respiratory samples (n=31/95; 33%) included lymph nodes (n=20), and other sterile fluids (n=11). Specimens were examined using AFB microscopy, Gen-Probe and bacterial culture using BACTECTM MGITTM 960 (Becton Dickinson, USA) and Löwenstein-Jensen (LJ) media. The clinical diagnosis of TB was made in 34/81 (42%) children (29/34 with pulmonary disease). Direct smear was positive for AFB in 2/34 (6%) children; Mycobacterium tuberculosis (ΜΤΒ) was recovered by culture from 13/34 (38%) and AMTD was positive in 20/34 (59%). Based on clinical diagnosis, the sensitivity, specificity, PPV and NPV of the AMTD test vs. culture were 59%, 96%, 91%, and 76% vs. 38%, 98%, 93% and 69%, respectively. For pulmonary vs. extra-pulmonary disease the performance of AMTD compared to culture was: 100%, 87%, 67%, 100% vs. 75%, 96%, 75% and 96%, respectively. Nucleic acid amplification tests are more sensitive and very specific methods for the (rapid) detection of MTB compared to culture in children with TB. The Gen-Probe technique increases TB detection in children by about 55% compared to culture.
The aim of the study was to evaluate the performance of Gen-Probe Amplified Mycobacterium tuberculosis Direct Test (AMTD, Gen-Probe, San Diego, California) for the diagnosis of tuberculosis in children, compared to conventional culture and clinical diagnosis. We retrospectively studied 81 children (48 males; mean age 7 years; range 1-16 years) evaluated for possible active TB. Respiratory samples (n=64/95;67%) submitted to NRLM included gastric aspirates (n=30), induced sputa (n=30), bronchial aspirates and bronho-alveolar lavage (n=4). Non-respiratory samples (n=31/95; 33%) included lymph nodes (n=20), and other sterile fluids (n=11). Specimens were examined using AFB microscopy, Gen-Probe and bacterial culture using BACTECTM MGITTM 960 (Becton Dickinson, USA) and Löwenstein-Jensen (LJ) media. The clinical diagnosis of TB was made in 34/81 (42%) children (29/34 with pulmonary disease). Direct smear was positive for AFB in 2/34 (6%) children; Mycobacterium tuberculosis (ΜΤΒ) was recovered by culture from 13/34 (38%) and AMTD was positive in 20/34 (59%). Based on clinical diagnosis, the sensitivity, specificity, PPV and NPV of the AMTD test vs. culture were 59%, 96%, 91%, and 76% vs. 38%, 98%, 93% and 69%, respectively. For pulmonary vs. extra-pulmonary disease the performance of AMTD compared to culture was: 100%, 87%, 67%, 100% vs. 75%, 96%, 75% and 96%, respectively. Nucleic acid amplification tests are more sensitive and very specific methods for the (rapid) detection of MTB compared to culture in children with TB. The Gen-Probe technique increases TB detection in children by about 55% compared to culture.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies